Institutional investors purchased a net $310.4 thousand shares of NWBO during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 21.34% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 467.5 Thousand shares of Northwest Biotherapeutics...